Health and economic impact of rotavirus vaccination in GAVI-eligible countries

Kim, Sun-Young; Sweet, Steve; Slichter, David; Goldie, Sue J

doi:10.1186/1471-2458-10-253

BMC Public Health

Table 4 Cost-effectiveness of rotavirus vaccination in the GAVI-eligible countries

From: Health and economic impact of rotavirus vaccination in GAVI-eligible countries

Country	Base-case vaccine efficacy (adjusted for serotype distribution)			Vaccine efficacy based on SAGE recommendation
	ICER^a(I$/DALY averted) I$10 per vaccinated child	ICER^a(I$/DALY averted) I$25 per vaccinated child	ICER^b(I$/DALY averted) based on GAVI's co-financing scheme	ICER^a(I$/DALY averted) I$10 per vaccinated child	ICER^a(I$/DALY averted) I$25 per vaccinated child	ICER^b(I$/DALY averted) based on GAVI's co-financing scheme
AFR D
Angola	saving	26	4	0.2	68	22
Benin	25	108	52	57	190	87
Burkina Faso	22	90	37	42	141	59
Cameroon	22	108	57	54	190	93
Chad	saving	54	33	17	113	59
Comoros	119	341	150	122	348	153
Ghana	71	221	100	142	398	176
Guinea	18	99	54	49	178	88
Guinea-Bissau	7	68	37	26	113	57
Liberia	17	67	32	37	114	53
Madagascar	20	124	65	60	225	108
Mali	5	58	29	26	109	51
Mauritania	21	116	52	58	209	92
Niger	saving	36	23	10	78	42
Nigeria	27	102	48	51	162	74
Sao Thome	40	152	65	83	262	112
Senegal	32	125	56	68	215	95
Sierra Leone	2	41	21	17	79	37
The Gambia	59	196	87	112	328	145
Togo	46	155	75	88	262	121
AFR E
Burundi	22	84	44	46	145	70
Central African Republic	20	96	46	50	171	78
Congo	74	250	111	143	422	185
Cote d'Ivoire	21	95	47	44	153	72
Democratic Republic of the Congo	19	76	39	41	131	62
Eritrea	95	266	117	97	272	120
Ethiopia	28	98	45	55	166	74
Kenya	37	150	68	81	260	115
Lesotho	397	1,061	459	655	1,707	737
Malawi	26	93	40	55	165	71
Mozambique	31	115	48	64	198	83
Rwanda	1	58	30	23	114	54
Tanzania	42	147	66	87	258	114
Uganda	31	127	62	68	220	102
Zambia	23	103	45	49	166	72
Zimbabwe	78	251	110	134	391	170
AMR A, B & D
Cuba	11,332	28,443	12,240	11,909	29,888	12,862
Guyana	4	113	40	7	122	44
Honduras	85	386	190	95	411	201
Bolivia	47	246	120	53	262	128
Haiti	4	105	56	46	212	102
Nicaragua	217	646	289	234	688	307
EMR D
Afghanistan	saving	47	29	15	90	48
Djibouti	saving	90	54	25	179	92
Pakistan	42	192	102	95	325	159
Somalia	saving	39	32	11	83	51
Sudan	84	266	121	148	426	190
Yemen	26	160	82	73	276	132
EUR B & C
Armenia	227	685	312	254	753	341
Azerbaijan	saving	95	68	35	223	123
Georgia	131	429	206	148	473	225
Kyrgyzstan	59	215	99	68	239	109
Tajikistan	6	80	48	10	91	53
Uzbekistan	saving	122	58	saving	144	67
Moldova	1,763	4,497	1,949	1,925	4,900	2,122
Ukraine	4,816	12,161	5,243	5,249	13,245	5,710
SEAR B & D
Indonesia	80	302	136	90	326	146
Korea, Democratic Republic	118	363	154	129	390	165
Sri Lanka	487	1,303	565	522	1,391	603
Timor Leste	41	161	67	46	174	73
Bangladesh	50	209	104	52	216	106
Bhutan	38	175	75	44	190	81
India	54	201	97	53	198	96
Myanmar	28	137	74	75	256	126
Nepal	62	215	102	70	235	110
WPR B
Cambodia	saving	44	34	10	111	63
Kiribati	4	111	50	9	122	54
Lao People Democratic Republic	15	132	77	20	144	83
Mongolia	77	274	114	85	296	123
Papua New Guinea	saving	84	36	saving	95	41
Solomon Islands	143	444	186	156	476	200
Viet Nam	193	799	390	228	885	427

I$ = International dollars; DALY = Disability-adjusted life year; ICER = Incremental cost-effectiveness ratio.
AFR = African Region; EMR = Eastern Mediterranean Region; EUR = European Region; AMR = Region of the Americas; WPR = Western Pacific Region; SEAR = South-East Asian Region.
a ICERs are for a strategy of vaccinating 70% of a single birth cohort born in 2010 assuming a vaccination program cost of I$10 and I$25 per vaccinated child compared to no vaccination.
b ICERs are for a strategy of vaccinating 70% of a single birth cohort born in 2010, but vaccination program costs vary across countries according to the GAVI's co-financing scheme [32].

Back to article page

ISSN: 1471-2458

Contact us

Submission enquiries: bmcpublichealth@biomedcentral.com
General enquiries: ORSupport@springernature.com